Revenues were $0.00.
The company reported a net income of $-10.88M.
Cannbiorx Life Sciences reported a free cash flow of $-3.87M
for its fiscal year, compared to $-3.46M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
New Investing Guides
Cannabis Stocks Guide
Psychedelic Stocks Guide